Aristides Capital LLC Novan, Inc. Transaction History

Aristides Capital LLC

  • $219 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$2.95 - $4.41 $59,837 - $89,452
-20,284 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$4.03 - $8.15 $81,744 - $165,314
20,284 New
20,284 $85,000

About Novan, Inc.

NOVN Quotes by TradingView
  • Ticker NOVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 21,281,600
  • Market Cap $638K
  • Description
  • Novan, Inc., a pre-commercial nitric oxide-based pharmaceutical company, focuses on dermatology and anti-infective therapies. Its clinical stage dermatology drug candidates include SB204, a topical monotherapy for the treatment of acne vulgaris; SB206, a topical anti-viral gel for the treatment of viral skin infections; SB208, a topical broad-sp...
More about NOVN
Track This Portfolio

Track Aristides Capital LLC Portfolio

Follow Aristides Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aristides Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aristides Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email